Skip to main content
Top
Published in: Digestive Diseases and Sciences 1/2019

Open Access 01-01-2019 | Original Article

The Clinicopathological Correlations of hTERC Amplification with Esophageal Squamous Cell Precursor Lesions

Authors: Yanping Hu, Xiaojing Teng, Linlin Wu, Wei Liu, Jianduo An

Published in: Digestive Diseases and Sciences | Issue 1/2019

Login to get access

Abstract

Background

Esophageal squamous cell precursor lesions remain one of the most controversial topics in pathology and clinical management.

Aims

To analyze the dysregulation of human telomerase RNA component (hTERC) in esophageal squamous cell precursor lesions and the clinicopathological correlations with the characteristics of esophageal squamous cell precursor lesions.

Methods

Florescence in situ hybridization was performed to detect hTERC amplification in different gradings of esophageal squamous cell precursor lesions. With retrospective follow-up data, clinicopathological correlations between hTERC and esophageal squamous cell precursor lesions were subjected to logistic regression analysis.

Results

hTERC amplification gradually increased with upgrading of dysplasia, reaching the highest level in high-grade intraepithelial neoplasia, and there was a significant difference between the low-grade intraepithelial neoplasia group and the high-grade intraepithelial neoplasia group (P = 0.00). Logistic regression analysis showed that hTERC amplification was correlated with both dysplasia grading and ulcer characteristics of esophageal squamous cell precursor lesions (P < 0.05).

Conclusions

hTERC amplification with increasing grading of esophageal squamous cell precursor lesions and the presence of ulcer characteristics might provide an important molecular and pathological marker for the diagnosis and clinical prognosis of esophageal squamous cell precursor lesions, especially for those ambiguous cases with more divergence in classification.
Literature
1.
go back to reference Kamangar F, Dores GM, Anderson WF. Patterns of cancer incidence, mortality, and prevalence across five continents: Defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol. 2006;24:2137–2150.CrossRef Kamangar F, Dores GM, Anderson WF. Patterns of cancer incidence, mortality, and prevalence across five continents: Defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol. 2006;24:2137–2150.CrossRef
2.
go back to reference Guo JH, Xing GL, Fang XH, et al. Proteomic profiling of fetal esophageal epithelium, esophageal cancer, and tumor-adjacent esophageal epithelium and immunohistochemical characterization of a representative differential protein, PRX6. World J Gastroenterol. 2017;23:1434–1442.CrossRef Guo JH, Xing GL, Fang XH, et al. Proteomic profiling of fetal esophageal epithelium, esophageal cancer, and tumor-adjacent esophageal epithelium and immunohistochemical characterization of a representative differential protein, PRX6. World J Gastroenterol. 2017;23:1434–1442.CrossRef
3.
go back to reference Ohashi S, Miyamoto S, Kikuchi O, Goto T, Amanuma Y, Muto M. Recent advances from basic and clinical studies of esophageal squamous cell carcinoma. Gastroenterology. 2015;149:1700–1715.CrossRef Ohashi S, Miyamoto S, Kikuchi O, Goto T, Amanuma Y, Muto M. Recent advances from basic and clinical studies of esophageal squamous cell carcinoma. Gastroenterology. 2015;149:1700–1715.CrossRef
4.
go back to reference Jesinghaus M, Steiger K, Slotta-Huspenina J, et al. Increased intraepithelial CD3 + T-lymphocytes and high PD-L1 expression on tumor cells are associated with favorable prognosis in esophageal squamous cell carcinoma and allow prognostic immunogenic subgrouping. Oncotarget. 2017;8:46756–46768.CrossRef Jesinghaus M, Steiger K, Slotta-Huspenina J, et al. Increased intraepithelial CD3 + T-lymphocytes and high PD-L1 expression on tumor cells are associated with favorable prognosis in esophageal squamous cell carcinoma and allow prognostic immunogenic subgrouping. Oncotarget. 2017;8:46756–46768.CrossRef
5.
go back to reference Wang GQ, Abnet CC, Shen Q, et al. Histological precursors of oesophageal squamous cell carcinoma: results from a 13 year prospective follow up study in a high risk population. Gut. 2005;54:187–192.CrossRef Wang GQ, Abnet CC, Shen Q, et al. Histological precursors of oesophageal squamous cell carcinoma: results from a 13 year prospective follow up study in a high risk population. Gut. 2005;54:187–192.CrossRef
6.
go back to reference Morin GB. The human telomere terminal transferase enzyme is a ribonucleoprotein that synthesizes TTAGGG repeats. Cell. 1989;59:521–529.CrossRef Morin GB. The human telomere terminal transferase enzyme is a ribonucleoprotein that synthesizes TTAGGG repeats. Cell. 1989;59:521–529.CrossRef
7.
go back to reference Fu D, Collins K. Purification of human telomerase complexes identifies factors involved in telomerase biogenesis and telomere length regulation. Mol Cell. 2007;28:773–785.CrossRef Fu D, Collins K. Purification of human telomerase complexes identifies factors involved in telomerase biogenesis and telomere length regulation. Mol Cell. 2007;28:773–785.CrossRef
8.
go back to reference Lewis KA, Tollefsbol TO. Regulation of the telomerase reverse transcriptase subunit through epigenetic mechanisms. Front Genet. 2016;9:83. Lewis KA, Tollefsbol TO. Regulation of the telomerase reverse transcriptase subunit through epigenetic mechanisms. Front Genet. 2016;9:83.
9.
go back to reference Xu Y, Goldkorn A. Telomere and telomerase therapeutics in cancer. Genes (Base). 2016;7:E22.CrossRef Xu Y, Goldkorn A. Telomere and telomerase therapeutics in cancer. Genes (Base). 2016;7:E22.CrossRef
10.
go back to reference Wang J, Wang LP, Xu S, Yang GZ. Morphology, immunohistochemistry and hTERC gene in situ hybridization in Barrett’s esophagus. Zhonghua Bing Li Xue Za Zhi. 2013;42:4–9.PubMed Wang J, Wang LP, Xu S, Yang GZ. Morphology, immunohistochemistry and hTERC gene in situ hybridization in Barrett’s esophagus. Zhonghua Bing Li Xue Za Zhi. 2013;42:4–9.PubMed
11.
go back to reference Hsu CP, Lee LW, Shai SE, Chen CY. Clinical significance of telomerase and its associate genes expression in the maintenance of telomere length in squamous cell carcinoma of the esophagus. World J Gastroenterol. 2005;11:6941–6947.CrossRef Hsu CP, Lee LW, Shai SE, Chen CY. Clinical significance of telomerase and its associate genes expression in the maintenance of telomere length in squamous cell carcinoma of the esophagus. World J Gastroenterol. 2005;11:6941–6947.CrossRef
12.
go back to reference Wang YF, Wang XS, Gao SG, et al. Clinical significance of combined detection of human papilloma virus infection and human telomerase RNA component gene amplification in patients with squamous cell carcinoma of the esophagus in northern China. Eur J Med Res. 2013;18:11.CrossRef Wang YF, Wang XS, Gao SG, et al. Clinical significance of combined detection of human papilloma virus infection and human telomerase RNA component gene amplification in patients with squamous cell carcinoma of the esophagus in northern China. Eur J Med Res. 2013;18:11.CrossRef
13.
go back to reference Bosman FT, Carneiro F, Hruban RH, Theise ND. WHO Classification of Tumours of the Digestive System. Lyon: IARC Press; 2010:22–23. Bosman FT, Carneiro F, Hruban RH, Theise ND. WHO Classification of Tumours of the Digestive System. Lyon: IARC Press; 2010:22–23.
14.
go back to reference Hamilton Stanley R, Aaltonen Lauri A. World Health Organization Classification of Tumours. Pathology and Genetics. Tumours of the Digestive System. Lyon: IARC Press; 2000:15–16. Hamilton Stanley R, Aaltonen Lauri A. World Health Organization Classification of Tumours. Pathology and Genetics. Tumours of the Digestive System. Lyon: IARC Press; 2000:15–16.
15.
go back to reference Shimizu M, Nagata K, Yamaguchi H, Kita H. Squamous intraepithelial neoplasia of the esophagus: Past, present, and future. J Gastroenterol. 2009;44:103–112.CrossRef Shimizu M, Nagata K, Yamaguchi H, Kita H. Squamous intraepithelial neoplasia of the esophagus: Past, present, and future. J Gastroenterol. 2009;44:103–112.CrossRef
16.
go back to reference Skacel M, Petras RE, Gramlich TL, Sigel JE, Richter JE, Goldblum JR. The diagnosis of low-grade dysplasia in Barrett’s esophagus and its implications for disease progression. Am J Gastroenterol. 2000;95:3383–3387.CrossRef Skacel M, Petras RE, Gramlich TL, Sigel JE, Richter JE, Goldblum JR. The diagnosis of low-grade dysplasia in Barrett’s esophagus and its implications for disease progression. Am J Gastroenterol. 2000;95:3383–3387.CrossRef
17.
go back to reference Griffith JD, Comeau L, Rosenfield S, et al. Mammalian telomeres end in a large duplex loop. Cell. 1999;97:503–514.CrossRef Griffith JD, Comeau L, Rosenfield S, et al. Mammalian telomeres end in a large duplex loop. Cell. 1999;97:503–514.CrossRef
18.
go back to reference Wright WE, Piatyszek MA, Rainey WE, Byrd W, Shay JW. Telomerase activity in human germline and embryonic tissues and cells. Dev Genet. 1996;18:173–179.CrossRef Wright WE, Piatyszek MA, Rainey WE, Byrd W, Shay JW. Telomerase activity in human germline and embryonic tissues and cells. Dev Genet. 1996;18:173–179.CrossRef
19.
go back to reference Forsyth NR, Wright WE, Shay JW. Telomerase and differentiation in multicellular organisms: turn it off, turn it on, and turn it off again. Differentiation. 2002;69:188–197.CrossRef Forsyth NR, Wright WE, Shay JW. Telomerase and differentiation in multicellular organisms: turn it off, turn it on, and turn it off again. Differentiation. 2002;69:188–197.CrossRef
20.
go back to reference Oishi T, Kigawa J, Minagawa Y, Shimada M, Takahashi M, Terakawa N. Alteration of telomerase activity associated with development and extension of epithelial ovarian cancer. Obstet Gynecol. 1998;91:568–571.PubMed Oishi T, Kigawa J, Minagawa Y, Shimada M, Takahashi M, Terakawa N. Alteration of telomerase activity associated with development and extension of epithelial ovarian cancer. Obstet Gynecol. 1998;91:568–571.PubMed
21.
go back to reference Swellam M, Ismail M, Eissa S, Hamdy M, Mokhtar N. Emerging role of p53, bcl-2 and telomerase activity in Egyptian breast cancer patients. IUBMB Life. 2004;56:483–490.CrossRef Swellam M, Ismail M, Eissa S, Hamdy M, Mokhtar N. Emerging role of p53, bcl-2 and telomerase activity in Egyptian breast cancer patients. IUBMB Life. 2004;56:483–490.CrossRef
22.
go back to reference Xie XC, Ge LY, Lai H, Qiu H, Tang F, Qin YZ. The relationship between telomerase activity and clinicopathological parameters in colorectal cancer: A meta-analysis. Balkan Med J. 2016;33:64–671.CrossRef Xie XC, Ge LY, Lai H, Qiu H, Tang F, Qin YZ. The relationship between telomerase activity and clinicopathological parameters in colorectal cancer: A meta-analysis. Balkan Med J. 2016;33:64–671.CrossRef
23.
go back to reference Pirker C, Holzmann K, Spiegl-Kreinecker S, et al. Chromosomal imbalances in primary and metastatic melanomas: over-representation of essential telomerase genes. Melanoma Res. 2003;13:483–492.CrossRef Pirker C, Holzmann K, Spiegl-Kreinecker S, et al. Chromosomal imbalances in primary and metastatic melanomas: over-representation of essential telomerase genes. Melanoma Res. 2003;13:483–492.CrossRef
24.
go back to reference Gay-Bellile M, Romero P, Cayre A, et al. ERCC1 and telomere status in breast tumours treated with neoadjuvant chemotherapy and their association with patient prognosis. J Pathol Clin Res. 2016;2:234–246.CrossRef Gay-Bellile M, Romero P, Cayre A, et al. ERCC1 and telomere status in breast tumours treated with neoadjuvant chemotherapy and their association with patient prognosis. J Pathol Clin Res. 2016;2:234–246.CrossRef
25.
go back to reference Wang L, Li PF, Geng M, Cao YC, Yin YC. Correlation between chemosensitivity to anticancer drugs and telomerase reverse transcriptase mRNA expression in gastric cancer. Diagn Pathol. 2013;22:33. Wang L, Li PF, Geng M, Cao YC, Yin YC. Correlation between chemosensitivity to anticancer drugs and telomerase reverse transcriptase mRNA expression in gastric cancer. Diagn Pathol. 2013;22:33.
26.
go back to reference Deville L, Hillion J, Pendino F, Samy M, Nguyen E, Ségal-Bendirdjian E. hTERT promotes imatinib resistance in chronic myeloid leukemia cells: therapeutic implications. Mol Cancer Ther. 2011;10:711–719.CrossRef Deville L, Hillion J, Pendino F, Samy M, Nguyen E, Ségal-Bendirdjian E. hTERT promotes imatinib resistance in chronic myeloid leukemia cells: therapeutic implications. Mol Cancer Ther. 2011;10:711–719.CrossRef
27.
go back to reference Xu B, Li C, Sung C. Telomerase inhibitory effects of medicinal mushrooms and lichens, and their anticancer activity. Int J Med Mushrooms. 2014;16:17–28.CrossRef Xu B, Li C, Sung C. Telomerase inhibitory effects of medicinal mushrooms and lichens, and their anticancer activity. Int J Med Mushrooms. 2014;16:17–28.CrossRef
Metadata
Title
The Clinicopathological Correlations of hTERC Amplification with Esophageal Squamous Cell Precursor Lesions
Authors
Yanping Hu
Xiaojing Teng
Linlin Wu
Wei Liu
Jianduo An
Publication date
01-01-2019
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 1/2019
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-018-5318-7

Other articles of this Issue 1/2019

Digestive Diseases and Sciences 1/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.